Double labeling alpha-synuclein in labial minor salivary glands in Parkinson's disease and idiopathic RBD patients

被引：0
|
作者：
Mangone, G.
Houot, M.
Casas, S. Boluda
Chalancon, A.
Prigent, A.
Seilhean, D.
Corvol, J. C.
Vidailhet, M.
Duyckaerts, C.
Degos, B.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
788
引用
收藏
页码：S338 / S339
页数：2
相关论文
共 50 条
  • [31] Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson's disease
    Shaheen, Hala
    Sobhy, Sayed
    El Mously, Sherine
    Abuomira, Marwa
    Mansour, Mohamed
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2020, 56 (01):
  • [32] Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease
    Fabrizio Angius
    Ignazia Mocci
    Tommaso Ercoli
    Francesco Loy
    Laura Fadda
    Maria Francesca Palmas
    Giada Cannas
    Aldo Manzin
    Giovanni Defazio
    Anna R. Carta
    Journal of Neurology, 2023, 270 : 5613 - 5621
  • [33] Salivary Alpha-Synuclein a new tool for the diagnosis of Parkinson's disease? PARKSYN study
    Aertz, Cecile
    Gonzalez, Victoria
    Hirtz, Christophe
    Lehmann, Sylvain
    Deverdal, Marie
    Collombier, Laurent
    Castelnovo, Giovanni
    NEUROLOGY, 2018, 90
  • [34] Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease
    Angius, Fabrizio
    Mocci, Ignazia
    Ercoli, Tommaso
    Loy, Francesco
    Fadda, Laura
    Palmas, Maria Francesca
    Cannas, Giada
    Manzin, Aldo
    Defazio, Giovanni
    Carta, Anna R.
    JOURNAL OF NEUROLOGY, 2023, 270 (11) : 5613 - 5621
  • [35] Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
    Hala Shaheen
    Sayed Sobhy
    Sherine El Mously
    Marwa Abuomira
    Mohamed Mansour
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 56
  • [36] Phosphorylated α-synuclein immunoreactivity in nerve fibers from minor salivary glands in Parkinson's disease
    Carletti, Raffaella
    Campo, Flaminia
    Fusconi, Massimo
    Pellicano, Clelia
    De Vincentiis, Marco
    Pontieri, Francesco E.
    Di Gioia, Cira R.
    PARKINSONISM & RELATED DISORDERS, 2017, 38 : 99 - 101
  • [37] Alpha-synuclein levels and dimerization in erythrocytes of Parkinson's disease patients
    Papagiannakis, N.
    Koros, C.
    Stamelou, M.
    Simitsi, A. M.
    Maniati, M.
    Antonelou, R.
    Papadimitriou, D.
    Dermentzaki, G.
    Moraitou, M.
    Michelakakis, H.
    Stefanis, L.
    MOVEMENT DISORDERS, 2016, 31 : S205 - S205
  • [38] Parkinson's Disease, Cortical Dysfunction, and Alpha-Synuclein
    Caviness, John N.
    Lue, Lih-Fen
    Beach, Thomas G.
    Hentz, Joseph G.
    Adler, Charles H.
    Sue, Lucia
    Sadeghi, Ramin
    Driver-Dunckley, Erika
    Evidente, Virgilio G.
    Sabbagh, Marwan N.
    Shill, Holly A.
    Walker, Douglas G.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1436 - 1442
  • [39] Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
    Fields, Carroll Rutherford
    Bengoa-Vergniory, Nora
    Wade-Martins, Richard
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [40] Alpha-synuclein and the prion hypothesis in Parkinson's disease
    Melki, R.
    REVUE NEUROLOGIQUE, 2018, 174 (09) : 644 - 652
12345